What a parallel review actually is, and what it is not
When seizures are not controlled by medicines, an assessment may examine whether a procedure such as epilepsy surgery could help, weighing potential benefits against risks. That assessment is for selected people, and it does not by itself guarantee that surgery will follow or that seizures will stop. A review arranged from overseas is a records-based opinion: a specialist team reads your existing information and comments on it. It is not an examination, not a final decision, and not a substitute for the neurologist who knows you.
The practical value of running this in parallel is that you gain a second reading of complex material without dismantling the care you already have. Your local team continues to manage your medicines, appointments and safety. The China-side review adds an opinion you can discuss with them. If the two views differ, that difference is information to work through, not an instruction to switch.
Be clear about the limits before you start. A remote review cannot confirm your seizure type from a description alone, cannot examine you, and cannot observe how you respond to a change. It also cannot confirm hospital acceptance or a treatment slot. Those are decisions for the treating hospital and licensed clinicians after they see you and your records.
The records that make a review useful
The quality of a records-based opinion depends almost entirely on what the reviewing team can see. Vague summaries produce vague comments. The most useful file is one that lets a specialist reconstruct your history without guessing.
Seizure records matter most. A seizure diary with dates, descriptions, duration, what happened before and after, and any triggers gives the reviewer a picture of your pattern over time. Witness accounts help, because many people cannot describe their own seizures accurately. If you have video of an event, note whether it exists and how it can be shared.
EEG records are central. This includes the reports and, where available, the underlying tracings or files, not only a one-line conclusion. If you have had video-EEG monitoring, prolonged recordings or sleep-deprived studies, include them. Imaging such as MRI, with the report and the images or discs, is also relevant. Blood test results, especially levels of the medicines you take, help the reviewer understand what has already been tried and at what dose.
A written medicine history is essential: which medicines, at what doses, for how long, and what happened. A list of names alone is not enough, because the reason a medicine was stopped or continued is often the most informative part. Include any side effects that led to a change.
Finally, include a short statement in your own words of what you want answered. Are you asking whether an assessment for surgery is worth pursuing? Whether your current combination makes sense? Whether a different evaluation route exists? A focused question produces a focused reply.
Questions to put to both teams before anything changes
The coordination problem is rarely about willingness. It is about two clinical teams working from different information at different times. You can reduce that gap by asking both sides the same set of questions and sharing the answers.
Ask your local neurologist what they would want a second opinion to address, and whether there is any reason to avoid a particular route. Ask what they consider the next step if the review suggests one, and how they would want to be contacted. Ask whether they are willing to receive a written opinion and respond to it.
Ask the China-side team what their opinion will be based on, what they cannot assess from records, and what additional information would change their view. Ask who will write the opinion, in what language, and how it will be delivered. Ask whether they will communicate directly with your local team or only with you.
Ask both sides the same safety question: if a review recommends a change, who is responsible for implementing it, and how will that be monitored? A recommendation without a named clinician to act on it is not a plan. This is the point where many overseas enquiries stall, and it is worth resolving before you invest in the process.
Why a preliminary reply is not a decision
You may receive an initial response that says your case looks suitable for further assessment, or that more records are needed. Read that carefully. A preliminary reply usually means the team can see enough to continue the conversation, not that they have concluded anything clinical.
The distinction matters because it changes what you do next. If a reply asks for specific missing records, that is a request for information, not a rejection or an acceptance. If it says a multidisciplinary discussion would be useful, that describes a process, not an outcome. If it declines to comment, that may reflect incomplete records rather than your suitability.
Treat every preliminary reply as a step in a sequence. The sequence is: share records, clarify what is missing, obtain a records-based opinion, discuss it with your local team, and only then decide whether travel or further assessment makes sense. Skipping to travel arrangements before the opinion exists puts the cart before the horse.
If a reply is unclear, ask a direct question: what specifically is missing, and what would the next step be once it arrives? A useful reviewer will answer that plainly.
Keeping your local care uninterrupted
The single most important rule is that you do not stop or change any medicine because of an overseas enquiry. Seizure medicines should only be altered by a clinician who is managing your care and can monitor the consequences. Abrupt changes can be dangerous.
Keep every local appointment. Tell your neurologist that you are seeking a records-based opinion and ask them to remain your primary point of contact. If the review produces a recommendation, bring it to your local team rather than acting on it directly. They can judge whether it fits your situation, your other conditions and your monitoring needs.
If travel to China for assessment becomes relevant, plan it around your local care rather than instead of it. Ask your local team what they would want arranged before you go, what information they would want sent ahead, and how they want to be updated afterwards. Ask the China-side team the mirror questions.
There is also a practical handover question: who holds responsibility at each stage? Before any transition, confirm in writing which clinician is responsible for your medicines, which team is arranging tests, and who you contact if something changes. Ambiguity here is the main risk in cross-border care.
How ChinaSpecialistCare can help, and how to start
ChinaSpecialistCare provides non-clinical coordination for international patients. For this situation, that can include helping you organise seizure and EEG records into a clear file, arranging interpretation, and requesting a specialist appointment or a records-based opinion from a relevant hospital team. We do not diagnose, prescribe, decide suitability or promise that a hospital will accept your case. Those decisions belong to the treating hospital and licensed clinicians.
You can begin with a short summary through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require purchasing a proxy consultation. After first contact, we explain how to share records securely. Please do not send passport numbers, card details or a complete medical archive in the first message.
A useful first message states your main question, lists the medicines you have tried, and notes whether you have EEG and MRI records available. From there, the next step is to clarify what is missing and request a records-based opinion, which you then discuss with your local neurologist before deciding on anything further.
For more detail on how epilepsy assessment is approached in China, see the epilepsy surgery reference page linked below. It describes the assessment route; it does not promise that assessment leads to surgery.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.